Atıci Emine, Mogulkoc Rasim, Baltaci Abdulkerim Kasım, Menevse Esma
Health Sciences Faculty, Baskent University, Ankara, Turkey.
Department of Physiology, Medical School, Selcuk University, Konya, Turkey.
Horm Mol Biol Clin Investig. 2017 Aug 10;32(3):/j/hmbci.2017.32.issue-3/hmbci-2017-0033/hmbci-2017-0033.xml. doi: 10.1515/hmbci-2017-0033.
Background Changes in thyroid hormone concentrations may affect adiponectin concentrations through various mechanisms. A molecule released primarily from the fat cells adiposities; adiponectin has important effects on the regulation of body weight. Aim The present study aimed to explore the effects of experimental thyroid dysfunction and its treatment on nesfatin-1 and adiponectin levels in rats. Methods The study included 40 adult male Sprague-Dawley rats which were grouped as follows: (1) control; (2) hypothyroidism [hypothyroidism was induced by intraperitoneal injection of 10 mg/kg/day propylthiouracil (PTU) for 3 weeks]; (3) hypothyroidism + thyroxine group [after hypothyroidism was induced by 2-week PTU injection, they were treated with high-dose L-thyroxine (1.5 mg/kg/day) for 1 week]; (4) hyperthyroidism [hyperthyroidism was induced by 3-weeks' thyroxine injection (0.3 mg/kg/day)]; (5) hyperthyroidism + PTU (after hyperthyroidism was induced by 2-weeks' thyroxine injection, the animals were given 10 mg/kg/day PTU for 1 week). Blood samples taken at the end of the study were analyzed to measure nesfatin-1 and adiponectin levels. Results It was found that nesfatin-1 levels increased in hypothyroidism, while adiponectin levels decreased (p < 0.001). In experimental hyperthyroidism, on the other hand, both nesfatin-1 and adiponectin levels were found significantly elevated (p < 0.001). Conclusion The results of the study indicate that nesfatin-1 and adiponectin levels were modified considerably in hypo- and hyperthyroidism, whereas with the restoration of the thyroid function, modified hormone levels went back to normal.
背景 甲状腺激素浓度的变化可能通过多种机制影响脂联素浓度。脂联素是一种主要由脂肪细胞释放的分子,对体重调节具有重要作用。目的 本研究旨在探讨实验性甲状腺功能障碍及其治疗对大鼠中神经肽Y(Nesfatin-1)和脂联素水平的影响。方法 该研究纳入40只成年雄性Sprague-Dawley大鼠,分组如下:(1)对照组;(2)甲状腺功能减退组[通过腹腔注射10 mg/kg/天丙硫氧嘧啶(PTU)3周诱导甲状腺功能减退];(3)甲状腺功能减退+甲状腺素组[在通过PTU注射2周诱导甲状腺功能减退后,用高剂量L-甲状腺素(1.5 mg/kg/天)治疗1周];(4)甲状腺功能亢进组[通过注射甲状腺素(0.3 mg/kg/天)3周诱导甲状腺功能亢进];(5)甲状腺功能亢进+PTU组[在通过注射甲状腺素2周诱导甲状腺功能亢进后,给予动物10 mg/kg/天PTU 1周]。在研究结束时采集血样,分析测量Nesfatin-1和脂联素水平。结果 发现甲状腺功能减退时Nesfatin-1水平升高,而脂联素水平降低(p<0.001)。另一方面,在实验性甲状腺功能亢进中,Nesfatin-1和脂联素水平均显著升高(p<0.001)。结论 研究结果表明,甲状腺功能减退和亢进时Nesfatin-1和脂联素水平有显著改变,而随着甲状腺功能的恢复,改变的激素水平恢复正常。